{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T08:11:32Z","timestamp":1791447092057,"version":"4.3.3"},"reference-count":243,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. vasc. bras."],"abstract":"<jats:p>Abstract Patients with peripheral artery disease and generalized atherosclerosis are at high risk of cardiovascular and limb complications, affecting both quality of life and longevity. Lower limb atherosclerotic disease is associated with high cardiovascular morbidity and mortality and adequate management is founded on treatments involving patient-dependent factors, such as lifestyle changes, and physician-dependent factors, such as clinical treatment, endovascular treatment, or conventional surgery. Medical management of peripheral artery disease is multifaceted, and its most important elements are reduction of cholesterol level, antithrombotic therapy, control of arterial blood pressure, control of diabetes, and smoking cessation. Adhesion to this regime can reduce complications related to the limbs, such as chronic limb-threatening ischemia, that can result in amputation, and the systemic complications of atherosclerosis, such as stroke and myocardial infarction.<\/jats:p>","DOI":"10.1590\/1677-5449.202300592","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T11:37:28Z","timestamp":1730115448000},"source":"Crossref","is-referenced-by-count":8,"title":["Brazilian Society of Angiology and Vascular Surgery guidelines on peripheral artery disease"],"prefix":"10.1590","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6650-1145","authenticated-orcid":false,"given":"Fabiano Luiz","family":"Erzinger","sequence":"first","affiliation":[{"name":"Hospital Erasto Gaertner,  Brasil; Sociedade Brasileira de Angiologia e de Cirurgia Vascular,  Brasil; Instituto da Circula\u00e7\u00e3o,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0825-5529","authenticated-orcid":false,"given":"Afonso C\u00e9sar","family":"Polimanti","sequence":"additional","affiliation":[{"name":"Sociedade Brasileira de Angiologia e de Cirurgia Vascular,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7366-6685","authenticated-orcid":false,"given":"Daniel Mendes","family":"Pinto","sequence":"additional","affiliation":[{"name":"Sociedade Brasileira de Angiologia e de Cirurgia Vascular,  Brasil; Hospital Felicio Rocho Ringgold,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1175-0795","authenticated-orcid":false,"given":"Gustavo","family":"Murta","sequence":"additional","affiliation":[{"name":"Sociedade Brasileira de Angiologia e de Cirurgia Vascular,  Brasil; Rede Mater Dei de Sa\u00fade,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1835-3619","authenticated-orcid":false,"given":"Marcus Vinicius","family":"Cury","sequence":"additional","affiliation":[{"name":"Sociedade Brasileira de Angiologia e de Cirurgia Vascular,  Brasil; Instituto de Assist\u00eancia ao Servidor P\u00fablico Estadual de S\u00e3o Paulo,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7260-5522","authenticated-orcid":false,"given":"Ricardo Bernardo da","family":"Silva","sequence":"additional","affiliation":[{"name":"Sociedade Brasileira de Angiologia e de Cirurgia Vascular,  Brasil; Pontif\u00edcia Universidade Cat\u00f3lica do Paran\u00e1,  Brasil; Santa Casa de Londrina,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9178-6122","authenticated-orcid":false,"given":"Rodrigo Bruno","family":"Biagioni","sequence":"additional","affiliation":[{"name":"Sociedade Brasileira de Angiologia e de Cirurgia Vascular,  Brasil; Instituto de Assist\u00eancia ao Servidor P\u00fablico Estadual de S\u00e3o Paulo,  Brasil; Sociedade Brasileira de Radiologia Intervencionista e Cirurgia Endovascular,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1458-5276","authenticated-orcid":false,"given":"Sergio Quilici","family":"Belckzac","sequence":"additional","affiliation":[{"name":"Sociedade Brasileira de Angiologia e de Cirurgia Vascular,  Brasil; Instituto de Aprimoramento e Pesquisa em Angiorradiologia e Cirurgia Endovascular,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7237-4771","authenticated-orcid":false,"given":"Edwaldo Edner","family":"Joviliano","sequence":"additional","affiliation":[{"name":"Sociedade Brasileira de Angiologia e de Cirurgia Vascular,  Brasil; Universidade de S\u00e3o Paulo,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1537-0285","authenticated-orcid":false,"given":"Walter Junior Boin de","family":"Araujo","sequence":"additional","affiliation":[{"name":"Sociedade Brasileira de Angiologia e de Cirurgia Vascular,  Brasil; Instituto da Circula\u00e7\u00e3o,  Brasil; Universidade Federal do Paran\u00e1,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1504-8763","authenticated-orcid":false,"given":"Julio Cesar Peclat de","family":"Oliveira","sequence":"additional","affiliation":[{"name":"Sociedade Brasileira de Angiologia e de Cirurgia Vascular,  Brasil; Universidade Federal do Estado do Rio de Janeiro,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2024]]},"reference":[{"issue":"9","key":"ref1","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jacc.2014.12.036","article-title":"Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC)","volume":"65","author":"Patel MR","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jvs.2016.03.420","article-title":"Reporting standards of the Society for Vascular Surgery for endovascular treatment of chronic lower extremity peripheral artery disease","volume":"64","author":"Stoner MC","year":"2016","journal-title":"J Vasc Surg"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0741-5214(97)70045-4","article-title":"Recommended standards for reports dealing with lower extremity ischemia: revised version","volume":"26","author":"Rutherford RB","year":"1997","journal-title":"J Vasc Surg"},{"issue":"6","key":"ref4","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.jvs.2009.09.044","article-title":"Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia","volume":"50","author":"Conte MS","year":"2009","journal-title":"J Vasc Surg"},{"issue":"9","key":"ref5","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","article-title":"2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS)","volume":"39","author":"Aboyans V","year":"2018","journal-title":"Eur Heart J"},{"issue":"12","key":"ref6","first-page":"e686","article-title":"2016 AHA\/ACC Guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","volume":"135","author":"Gerhard-Herman MD","year":"2017","journal-title":"Circulation"},{"issue":"6","key":"ref7","first-page":"1616","article-title":"ACCF\/ AHA\/ ACR\/ SCAI\/ SIR\/ SVM\/ SVN\/ SVS 2010 performance measures for adults with peripheral artery disease: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Performance Measures, the American College of Radiology, the Society for Cardiac Angiography and Interventions, the Society for Interventional Radiology, the Society for Vascular Medicine, the Society for Vascular Nursing, and the Society for Vascular Surgery (Writing Committee to Develop Clinical Performance Measures for Peripheral Artery Disease)","volume":"52","author":"Olin JW","year":"2010","journal-title":"J Vasc Surg"},{"issue":"9901","key":"ref8","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: A systematic review and analysis","volume":"382","author":"Fowkes FGR","year":"2013","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.atherosclerosis.2021.03.019","article-title":"Sex related differences in therapy and outcome of patients with intermittent claudication in a real-world cohort","volume":"325","author":"Makowski L","year":"2021","journal-title":"Atherosclerosis"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1177\/145749691210100204","article-title":"Role and management of coagulation disorders in peripheral arterial disease","volume":"101","author":"Lassila R","year":"2012","journal-title":"Scand J Surg"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ejvs.2004.11.001","article-title":"Markers of coagulation activation, endothelial stimulation and inflammation in patients with peripheral arterial disease","volume":"29","author":"Cassar K","year":"2005","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1177\/1708538120915997","article-title":"Altered coagulation profile in peripheral artery disease patients","volume":"28","author":"Zamzam A","year":"2020","journal-title":"Vascular"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.3390\/ijms22031472","article-title":"Role, laboratory assessment and clinical relevance of fibrin, factor XIII and endogenous fibrinolysis in arterial and venous thrombosis","volume":"22","author":"Memtsas V","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/jama.300.2.197","article-title":"Ankle brachial index combined with framingham risk score to predict cardiovascular events and mortality: a meta-analysis","volume":"300","author":"Fowkes F","year":"2008","journal-title":"JAMA"},{"issue":"12","key":"ref15","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1080\/14779072.2020.1833719","article-title":"Antithrombotic strategies for patients with coronary and lower extremity peripheral artery diseases: a narrative review","volume":"18","author":"De Luca L","year":"2020","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s12325-019-01132-z","article-title":"Real-world predictors of major adverse cardiovascular events and major adverse limb events among patients with chronic coronary artery disease and\/or peripheral arterial disease","volume":"37","author":"Berger A","year":"2020","journal-title":"Adv Ther"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1055\/s-0040-1709711","article-title":"Statins and major adverse limb events in patients with peripheral artery disease: a systematic review and meta-analysis","volume":"120","author":"Pastori D","year":"2020","journal-title":"Thromb Haemost"},{"issue":"25","key":"ref18","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1016\/j.jacc.2018.09.078","article-title":"Cardiovascular and limb outcomes in patients with diabetes and peripheral artery disease","volume":"72","author":"Wang CCL","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"ref19","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ahj.2012.12.002","article-title":"High mortality risks after major lower extremity amputation in Medicare patients with peripheral artery disease","volume":"165","author":"Jones WS","year":"2013","journal-title":"Am Heart J"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1161\/ATVBAHA.119.312142","article-title":"Evidence-based medical management of peripheral artery disease","volume":"40","author":"Bevan GH","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"ref21","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.mayocp.2017.01.001","article-title":"Clinical practice guidelines: a primer on development and dissemination","volume":"92","author":"Murad MH","year":"2017","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"ref22","first-page":"501","article-title":"Cross-cultural adaptation and validation of the Brazilian Portuguese version of the Edinburgh Claudication Questionnaire","volume":"88","author":"Makdisse M","year":"2007","journal-title":"Arq Bras Cardiol"},{"issue":"10","key":"ref23","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/0895-4356(92)90150-L","article-title":"The Edinburgh Claudication Questionnaire: an improved version of the WHO\/Rose questionnaire for use in epidemiological surveys","volume":"45","author":"Leng GC","year":"1992","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"ref24","first-page":"306","article-title":"Diagnosis and treatment of peripheral arterial disease","volume":"88","author":"Hennion DR","year":"2013","journal-title":"Am Fam Physician"},{"issue":"24","key":"ref25","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1161\/CIR.0b013e318276fbcb","article-title":"Measurement and inter- pretation of the Ankle-Brachial Index: a scientific statement from the American Heart Association","volume":"126","author":"Aboyans V","year":"2012","journal-title":"Circulation"},{"issue":"5","key":"ref26","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1001\/jama.295.5.536","article-title":"Does the clinical examination predict lower extremity peripheral arterial disease?","volume":"295","author":"Khan NA","year":"2006","journal-title":"JAMA"},{"issue":"4","key":"ref27","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1177\/1358863X16645854","article-title":"A systematic review of the sensitivity and specificity of the toe-brachial index for detecting peripheral artery disease","volume":"21","author":"Tehan PE","year":"2016","journal-title":"Vasc Med"},{"issue":"8426","key":"ref28","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0140-6736(85)91144-4","article-title":"Drug-induced inhibition of platelet function delays progression of peripheral occlusive arterial disease. A prospective double-blind arteriographically controlled trial","volume":"1","author":"Hess H","year":"1985","journal-title":"Lancet"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0002-9343(01)01034-8","article-title":"Current medical therapies for patients with peripheral arterial disease: a critical review","volume":"112","author":"Regensteiner JG","year":"2002","journal-title":"Am J Med"},{"issue":"6","key":"ref30","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1586\/14779072.6.6.883","article-title":"Impact of tobacco smoking and smoking cessation on cardiovascular risk and disease","volume":"6","author":"Bullen C","year":"2008","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"9859","key":"ref31","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/S0140-6736(12)61766-8","article-title":"A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lim SS","year":"2012","journal-title":"Lancet"},{"issue":"11","key":"ref32","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1177\/2047487319832975","article-title":"Cardiovascular effects of electronic cigarettes: a systematic review and meta-analysis","volume":"26","author":"Skotsimara G","year":"2019","journal-title":"Eur J Prev Cardiol"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12954-020-00440-w","article-title":"How effective are electronic cigarettes for reducing respiratory and cardiovascular risk in smokers? A systematic review","volume":"17","author":"Goniewicz ML","year":"2020","journal-title":"Harm Reduct J"},{"key":"ref34","article-title":"Behavioural interventions for smoking cessation: an overview and network meta-analysis","volume":"1","author":"Hartmann-Boyce J","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"ref35","article-title":"Nicotine receptor partial agonists for smoking cessation","volume":"2016","author":"Cahill K","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"25","key":"ref36","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/j.jacc.2010.07.031","article-title":"Effectiveness of a smoking cessation program for peripheral artery disease patients: a randomized controlled trial","volume":"56","author":"Hennrikus D","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"ref37","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jvs.2021.07.248","article-title":"A meta-analysis of randomised controlled trials evaluating the efficacy of smoking cessation interventions in people with peripheral artery disease","volume":"75","author":"Thanigaimani S","year":"2022","journal-title":"J Vasc Surg"},{"issue":"3","key":"ref38","article-title":"Individual behavioural counselling for smoking cessation","volume":"3","author":"Lancaster T","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"ref39","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.2337\/diacare.24.8.1433","article-title":"Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome","volume":"24","author":"Jude EB","year":"2001","journal-title":"Diabetes Care"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.1016\/j.jcjd.2017.10.024","article-title":"Cardiovascular protection in people with diabetes","volume":"42","author":"Stone JA","year":"2018","journal-title":"Can J Diabetes"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.avsg.2018.05.054","article-title":"Metformin is associated with improved survival and decreased cardiac events with no impact on patency and limb salvage after revascularization for peripheral arterial disease","volume":"55","author":"Khan SZ","year":"2019","journal-title":"Ann Vasc Surg"},{"issue":"3","key":"ref42","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1001\/jama.2016.9400","article-title":"Comparison of clinical outcomes and adverse events associated with glucose-lowering drugs in patients with type 2 diabetes: a meta-analysis","volume":"316","author":"Palmer SC","year":"2016","journal-title":"JAMA"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.diabres.2019.05.028","article-title":"Peripheral artery disease and amputations with sodium-glucose co-transporter-2 (SGLT-2) inhibitors: a meta-analysis of randomized controlled trials","volume":"153","author":"Dicembrini I","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"issue":"12","key":"ref44","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1111\/dom.14159","article-title":"Sodium-glucose co-transporter-2 inhibitors and major adverse limb events: a trial-level meta-analysis including 51 713 individuals","volume":"22","author":"Huang CY","year":"2020","journal-title":"Diabetes Obes Metab"},{"issue":"11","key":"ref45","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S2213-8587(17)30309-1","article-title":"Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial","volume":"5","author":"Holman RR","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"ref46","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJMoa1203858","article-title":"Basal insulin and cardiovascular and other outcomes in dysglycemia","volume":"367","author":"Gerstein HC","year":"2012","journal-title":"N Engl J Med"},{"issue":"3","key":"ref47","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.amjmed.2016.10.016","article-title":"Dipeptidyl peptidase-4 inhibitors, peripheral arterial disease, and lower extremity amputation risk in diabetic patients","volume":"130","author":"Chang CC","year":"2017","journal-title":"Am J Med"},{"issue":"9","key":"ref48","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1007\/s00125-021-05497-1","article-title":"Major adverse cardiovascular and limb events in patients with diabetes treated with GLP-1 receptor agonists vs DPP-4 inhibitors","volume":"64","author":"Lin DSH","year":"2021","journal-title":"Diabetologia"},{"issue":"6","key":"ref49","doi-asserted-by":"crossref","first-page":"421","DOI":"10.7326\/0003-4819-141-6-200409210-00007","article-title":"Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus","volume":"141","author":"Selvin E","year":"2004","journal-title":"Ann Intern Med"},{"issue":"25","key":"ref50","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1056\/NEJMoa052187","article-title":"Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes","volume":"353","author":"Nathan DM","year":"2005","journal-title":"N Engl J Med"},{"issue":"5","key":"ref51","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/dom.12238","article-title":"Intensification of medication and glycaemic control among patients with type 2 diabetesdthe ADVANCE trial","volume":"16","author":"van Dieren S","year":"2014","journal-title":"Diabetes Obes Metab"},{"issue":"9","key":"ref52","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.2337\/dci15-0012","article-title":"Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the American Heart Association and the American Diabetes Association","volume":"38","author":"Fox CS","year":"2015","journal-title":"Diabetes Care"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.2337\/dc18-S006","article-title":"6. Glycemic targets: standards of medical care in diabetes-2018","volume":"41","year":"2018","journal-title":"Diabetes Care"},{"issue":"12","key":"ref54","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1007\/s00330-011-2225-0","article-title":"Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines","volume":"21","author":"Stacul F","year":"2011","journal-title":"Eur Radiol"},{"issue":"7","key":"ref55","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1007\/s00330-017-5247-4","article-title":"Post-contrast acute kidney injury. Part 2: risk stratification, role of hydration and other prophylactic measures, patients taking metformin and chronic dialysis patients: recommendations for updated ESUR Contrast Medium Safety Committee guidelines","volume":"28","author":"van der Molen AJ","year":"2018","journal-title":"Eur Radiol"},{"issue":"4","key":"ref56","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ejvs.2009.06.002","article-title":"Drug therapy for improving walking distance in intermittent claudication: a systematic review and meta-analysis of robust randomised controlled studies","volume":"38","author":"Momsen AH","year":"2009","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"4","key":"ref57","article-title":"Lipid-lowering for peripheral arterial disease of the lower limb","volume":"2007","author":"Aung PP","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"ref58","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jacc.2013.09.073","article-title":"Association between statin medications and mortality, major adverse cardiovascular event, and amputation-free survival in patients with critical limb ischemia","volume":"63","author":"Westin GG","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"ref59","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1161\/01.CIR.0000050380.64025.07","article-title":"Statin use and leg functioning in patients with and without lower-extremity peripheral arterial disease","volume":"107","author":"McDermott MM","year":"2003","journal-title":"Circulation"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1024\/0301-1526\/a000834","article-title":"ESVM guideline on peripheral arterial disease","volume":"48","author":"Frank U","year":"2019","journal-title":"Vasa"},{"issue":"1","key":"ref61","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009217.pub2","article-title":"Statins for the primary prevention of cardiovascular disease","volume":"2013","author":"Taylor F","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"ref62","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0002-9149(97)00904-1","article-title":"Effect of simvastatin on ischemic signs and symptoms in the Scandinavian simvastatin survival study (4S)","volume":"81","author":"Pedersen TR","year":"1998","journal-title":"Am J Cardiol"},{"issue":"6","key":"ref63","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jvs.2003.12.027","article-title":"Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts","volume":"39","author":"Abbruzzese TA","year":"2004","journal-title":"J Vasc Surg"},{"issue":"7","key":"ref64","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1210\/jc.2016-3717","article-title":"Statin therapy reduces future risk of lower-limb amputation in patients with diabetes and peripheral artery disease","volume":"102","author":"Hsu C-Y","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"41","key":"ref65","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1093\/eurheartj\/ehu080","article-title":"Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: insights from the REACH registry","volume":"35","author":"Kumbhani DJ","year":"2014","journal-title":"Eur Heart J"},{"issue":"12","key":"ref66","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1161\/01.CIR.0000090686.57897.F5","article-title":"Cholesterol reduction with ator- vastatin improves walking distance in patients with peripheral arterial disease","volume":"108","author":"Mohler 3rd ER","year":"2003","journal-title":"Circulation"},{"issue":"4","key":"ref67","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jvs.2007.11.056","article-title":"Statins are independently associated with reduced mortality in patients undergoing infrainguinal bypass graft surgery for critical limb ischemia","volume":"47","author":"Schanzer A","year":"2008","journal-title":"J Vasc Surg"},{"issue":"2","key":"ref68","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.vph.2014.09.001","article-title":"Statin therapy in lower limb peripheral arterial disease: systematic review and meta-analysis","volume":"63","author":"Antoniou GA","year":"2014","journal-title":"Vascul Pharmacol"},{"issue":"4","key":"ref69","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jvs.2006.12.054","article-title":"Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions","volume":"45","year":"2007","journal-title":"J Vasc Surg"},{"issue":"18","key":"ref70","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine MS","year":"2017","journal-title":"N Engl J Med"},{"issue":"9","key":"ref71","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1161\/CIRCRESAHA.116.303849","article-title":"Epidemiology of peripheral artery disease","volume":"116","author":"Criqui MH","year":"2015","journal-title":"Circ Res"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"h4865","DOI":"10.1136\/bmj.h4865","article-title":"Usual blood pressure, peripheral arterial disease, and vascular risk: cohort study of 4.2 million adults","volume":"351","author":"Emdin CA","year":"2015","journal-title":"BMJ"},{"issue":"3","key":"ref73","first-page":"516","article-title":"Brazilian guidelines of hypertension - 2020","volume":"116","author":"Barroso WKS","year":"2021","journal-title":"Arq Bras Cardiol"},{"issue":"10022","key":"ref74","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta- analysis","volume":"387","author":"Ettehad D","year":"2016","journal-title":"Lancet"},{"issue":"6","key":"ref75","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"71","author":"Whelton PK","year":"2018","journal-title":"Hypertension"},{"issue":"33","key":"ref76","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Williams B","year":"2018","journal-title":"Eur Heart J"},{"issue":"39","key":"ref77","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1093\/eurheartj\/ehab390","article-title":"Antithrombotic therapies in aortic and peripheral arterial diseases in 2021: a consensus document from the ESC working group on aorta and peripheral vascular diseases, the ESC working group on thrombosis, and the ESC working group on cardiovascular pharmacotherapy","volume":"42","author":"Aboyans V","year":"2021","journal-title":"Eur Heart J"},{"issue":"14","key":"ref78","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1161\/CIRCULATIONAHA.112.000679","article-title":"Vorapaxar in patients with peripheral artery disease: results from TRA2 P-TIMI 50","volume":"127","author":"Bonaca MP","year":"2013","journal-title":"Circulation"},{"issue":"2","key":"ref79","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/eurheartj\/ehn534","article-title":"Patients with peripheral arterial disease in the CHARISMA trial","volume":"30","author":"Cacoub PP","year":"2009","journal-title":"Eur Heart J"},{"issue":"2","key":"ref80","doi-asserted-by":"crossref","first-page":"a1840","DOI":"10.1136\/bmj.a1840","article-title":"The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease","volume":"337","author":"Belch J","year":"2008","journal-title":"BMJ"},{"issue":"9","key":"ref81","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/jama.2010.221","article-title":"Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial","volume":"303","author":"Fowkes FG","year":"2010","journal-title":"JAMA"},{"issue":"6","key":"ref82","first-page":"1085","article-title":"Aspirin for the primary prevention of cardiovascular events in patients with peripheral artery disease or diabetes mellitus: analyses from the JPAD, POPADAD and AAA trials","volume":"104","author":"Soejima H","year":"2010","journal-title":"Thromb Haemost"},{"issue":"2","key":"ref83","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1024\/0301-1526\/a000676","article-title":"Antithrombotic treatment in peripheral artery disease","volume":"47","author":"Olinic DM","year":"2018","journal-title":"Vasa"},{"issue":"5","key":"ref84","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.cjca.2022.02.029","article-title":"Canadian Cardiovascular Society 2022 guidelines for peripheral arterial disease","volume":"38","author":"Abramson BL","year":"2022","journal-title":"Can J Cardiol"},{"issue":"9038","key":"ref85","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","year":"1996","journal-title":"Lancet"},{"issue":"9678","key":"ref86","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Baigent C","year":"2009","journal-title":"Lancet"},{"issue":"23","key":"ref87","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1161\/CIRCULATIONAHA.121.055146","article-title":"Reduction in acute limb ischemia with rivaroxaban versus placebo in peripheral artery disease after lower extremity revascularization: insights from VOYAGER PAD","volume":"144","author":"Hess CN","year":"2021","journal-title":"Circulation"},{"issue":"10117","key":"ref88","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(17)32409-1","article-title":"Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial","volume":"391","author":"Anand SS","year":"2018","journal-title":"Lancet"},{"issue":"3","key":"ref89","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1365-2796.2006.01763.x","article-title":"Prevention of serious vascular events by aspirin amongst patients with peripheral arterial disease: randomized, double-blind trial","volume":"261","author":"Catalano M","year":"2007","journal-title":"J Intern Med"},{"issue":"7329","key":"ref90","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta- analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"issue":"5","key":"ref91","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2796.1990.tb00164.x","article-title":"Prevention of myocardial infarction and stroke in patients with intermittent claudication; effects of ticlopidine. Results from STIMS, the Swedish Ticlopidine Multicentre Study","volume":"227","author":"Janzon L","year":"1990","journal-title":"J Intern Med"},{"issue":"16","key":"ref92","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events","volume":"354","author":"Bhatt DL","year":"2006","journal-title":"N Engl J Med"},{"issue":"19","key":"ref93","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1500857","article-title":"Long-term use of ticagrelor in patients with prior myocardial infarction","volume":"372","author":"Bonaca MP","year":"2015","journal-title":"N Engl J Med"},{"issue":"13","key":"ref94","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1016\/S0735-1097(16)32267-7","article-title":"Efficacy and safety of ticagrelor as long-term secondary prevention in patients with prior myocardial infarction and peripheral artery disease","volume":"67","author":"Bonaca MP","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"ref95","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","article-title":"Rivaroxaban with or without Aspirin in stable cardiovascular disease","volume":"377","author":"Eikelboom JW","year":"2017","journal-title":"N Engl J Med"},{"issue":"20","key":"ref96","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1016\/j.jacc.2018.03.008","article-title":"Major adverse limb events and mortality in patients with peripheral artery disease: the COMPASS Trial","volume":"71","author":"Anand SS","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"ref97","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ejvs.2006.09.024","article-title":"Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)","volume":"33","author":"Norgren L","year":"2007","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"6","key":"ref98","doi-asserted-by":"crossref","first-page":"815S","DOI":"10.1378\/chest.08-0686","article-title":"Antithrombotic therapy for peripheral artery occlusive disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Sobel M","year":"2008","journal-title":"Chest"},{"issue":"18","key":"ref99","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1177\/2047487319846999","article-title":"Follow-up of patients after revascularisation for peripheral. arterial diseases: a consensus document from the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases and the European Society for Vascular Surgery","volume":"26","author":"Venermo M","year":"2019","journal-title":"Eur J Prev Cardiol"},{"issue":"3","key":"ref100","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0741-5214(98)70130-2","article-title":"Warfarin improves the outcome of infrainguinal vein bypass grafting at high risk. for failure","volume":"28","author":"Sarac TP","year":"1998","journal-title":"J Vasc Surg"},{"issue":"1","key":"ref101","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S1078-5884(05)80218-7","article-title":"Pathophysiology of vein graft failure: a review","volume":"9","author":"Davies MG","year":"1995","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"4","key":"ref102","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1055\/s-0032-1330232","article-title":"A review of the role of anticoagulation in the treatment of peripheral arterial disease","volume":"21","author":"Whayne Jr TF","year":"2012","journal-title":"Int J Angiol"},{"issue":"6","key":"ref103","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1590\/1516-3180.2020.0640.110321","article-title":"Evidence from Cochrane systematic reviews for effects of antithrombotic drugs for lower-limb revascularization: a narrative review","volume":"139","author":"Dias SVM","year":"2021","journal-title":"Sao Paulo Med J"},{"issue":"4","key":"ref104","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jvs.2010.04.027","article-title":"Results of the randomized, placebo- controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial","volume":"52","author":"Belch JJF","year":"2010","journal-title":"J Vasc Surg"},{"issue":"7329","key":"ref105","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta- analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"issue":"4","key":"ref106","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0741-5214(99)70109-6","article-title":"Systematic review of randomized controlled trials of aspirin and oral anticoagulants in the prevention of graft occlusion and ischemic events after infrainguinal bypass surgery","volume":"30","author":"Tangelder MJD","year":"1999","journal-title":"J Vasc Surg"},{"key":"ref107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1024\/0301-1526\/a000834","article-title":"ESVM Guideline on peripheral arterial disease","volume":"48","author":"Frank U","year":"2019","journal-title":"Vasa"},{"issue":"9201","key":"ref108","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0140-6736(99)07199-8","article-title":". Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral anticoagulants or Aspirin study): a randomised trial","volume":"355","year":"2000","journal-title":"Lancet"},{"issue":"21","key":"ref109","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"382","author":"Bonaca MP","year":"2020","journal-title":"N Engl J Med"},{"issue":"23","key":"ref110","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1161\/CIRCULATIONAHA.120.050465","article-title":"Rivaroxaban and aspirin in peripheral artery disease lower extremity revascularization: impact of concomitant clopidogrel on efficacy and safety","volume":"142","author":"Hiatt WR","year":"2020","journal-title":"Circulation"},{"issue":"6","key":"ref111","article-title":"Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery","volume":"2011","author":"Geraghty AJ","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"ref112","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/152660280200900111","article-title":"Balloon angioplasty and stent implantation induce a vascular inflammatory reaction","volume":"9","author":"Schillinger M","year":"2002","journal-title":"J Endovasc Ther"},{"issue":"2","key":"ref113","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1148\/radiol.2241011253","article-title":"Inflammatory response to stent implantation: differences in femoropopliteal, iliac, and carotid arteries","volume":"224","author":"Schillinger M","year":"2002","journal-title":"Radiology"},{"issue":"3","key":"ref114","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1177\/145749691210100306","article-title":"Predictors of failure of endovascular revascularization for critical limb ischemia","volume":"101","author":"Korhonen M","year":"2012","journal-title":"Scand J Surg"},{"issue":"1","key":"ref115","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0741-5214(03)00129-0","article-title":"Platelet activation is increased in peripheral arterial disease","volume":"38","author":"Cassar K","year":"2003","journal-title":"J Vasc Surg"},{"issue":"8","key":"ref116","article-title":"Antiplatelet and anticoagulant drugs for prevention of restenosis\/reocclusion following peripheral endovascular treatment","volume":"2012","author":"Robertson L","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"ref117","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1024\/0301-1526\/a000676","article-title":"Antithrombotic treatment in peripheral artery disease","volume":"47","author":"Olinic DM","year":"2018","journal-title":"Vasa"},{"issue":"1","key":"ref118","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.atherosclerosis.2013.10.027","article-title":"Response to antiplatelet therapy and platelet reactivity to thrombin receptor activating peptide-6 in cardiovascular interventions: differences between periph- eral and coronary angioplasty","volume":"232","author":"Gremmel T","year":"2014","journal-title":"Atherosclerosis"},{"issue":"9","key":"ref119","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1007\/s00330-012-2441-2","article-title":"Management of peripheral arterial interventions with mono or dual antiplatelet. therapy \u2013 the MIRROR study: a randomised and double-blinded clinical trial","volume":"22","author":"Tepe G","year":"2012","journal-title":"Eur Radiol"},{"issue":"23","key":"ref120","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1016\/j.jcin.2019.08.006","article-title":"Optimal strategy for antiplatelet therapy after endovascular revascularization for lower extremity peripheral artery disease","volume":"12","author":"Cho S","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"ref121","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1148\/radiology.193.2.7972781","article-title":"Low-dose aspirin combined with dipyridamole versus anticoagulants after femoropopliteal percutaneous transluminal angioplasty","volume":"193","author":"Do DD","year":"1994","journal-title":"Radiology"},{"issue":"4","key":"ref122","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.jvs.2014.11.067","article-title":"Cilostazol and freedom from amputation after lower extremity revascularization","volume":"61","author":"Neel JD","year":"2015","journal-title":"J Vasc Surg"},{"issue":"6","key":"ref123","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.jvs.2013.11.096","article-title":"Cilostazol is associated with improved outcomes after peripheral endovascular interventions","volume":"59","author":"Warner CJ","year":"2014","journal-title":"J Vasc Surg"},{"issue":"2","key":"ref124","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jvs.2020.08.125","article-title":"Literature review and meta-analysis of the efficacy of cilostazol on limb salvage rates after infrainguinal endovascular and open revascularization","volume":"73","author":"Desai K","year":"2021","journal-title":"J Vasc Surg"},{"issue":"12","key":"ref125","article-title":"Exercise for intermittent claudication","volume":"12","author":"Lane R","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"8","key":"ref126","article-title":"Modes of exercise training for intermittent claudication","volume":"8","author":"Jansen SC","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"ref127","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/jama.2013.7231","article-title":"Home-based walking exercise intervention in peripheral artery disease: a randomized clinical trial","volume":"310","author":"McDermott MM","year":"2013","journal-title":"JAMA"},{"issue":"5","key":"ref128","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jvs.2010.10.125","article-title":"Upper- versus lower-limb aerobic exercise training on health-related quality of life in patients with symptomatic peripheral arterial disease","volume":"53","author":"Saxton JM","year":"2011","journal-title":"J Vasc Surg"},{"issue":"7","key":"ref129","article-title":"Modes of exercise training for intermittent claudication","volume":"4","author":"Lauret GJ","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"ref130","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1161\/01.CIR.90.4.1866","article-title":"Superiority of treadmill walking exercise versus strength training for patients with peripheral arterial disease. Implications for the mechanism of the training response","volume":"90","author":"Hiatt WR","year":"1994","journal-title":"Circulation"},{"issue":"2","key":"ref131","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jvs.2010.02.022","article-title":"Multicenter randomized clinical trial of supervised exercise therapy with or without feedback versus walking advice for intermittent claudication","volume":"52","author":"Nicola\u00ef SPA","year":"2010","journal-title":"J Vasc Surg"},{"issue":"6","key":"ref132","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.ejvs.2008.10.007","article-title":"The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease","volume":"36","author":"Greenhalgh RM","year":"2008","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"2","key":"ref133","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ejvs.2011.02.019","article-title":"Walking performance and health-related quality of life after surgical or endovascular invasive versus noninvasive treatment for intermittent claudication: a prospective randomised trial","volume":"42","author":"Nordanstig J","year":"2011","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"6","key":"ref134","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1046\/j.1532-5415.2001.49152.x","article-title":"Exercise rehabilitation improves functional outcomes and peripheral circulation in patients with intermittent claudication: a randomized controlled trial","volume":"49","author":"Gardner AW","year":"2001","journal-title":"J Am Geriatr Soc"},{"issue":"12","key":"ref135","article-title":"Exercise for intermittent claudication","volume":"12","author":"Lane R","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"18","key":"ref136","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1001\/jama.2015.14851","article-title":"Endovascular revascularization and supervised exercise for peripheral artery disease and intermittent claudication: a randomized clinical trial","volume":"314","author":"Fakhry F","year":"2015","journal-title":"JAMA"},{"issue":"2","key":"ref137","first-page":"77","article-title":"A comparative study of upper body strength training exercise vs. treadmill walking on patients with intermittent claudication","volume":"7","author":"Jani CK","year":"2018","journal-title":"Archives of Clinical Experimental Surgery."},{"issue":"24","key":"ref138","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1056\/NEJMra021135","article-title":"Exercise training for claudication","volume":"347","author":"Stewart KJ","year":"2002","journal-title":"N Engl J Med"},{"issue":"2","key":"ref139","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jvs.2011.11.140","article-title":"Calf muscle oxygen saturation and the effects of supervised exercise training for intermittent claudication","volume":"56","author":"Beckitt TA","year":"2012","journal-title":"J Vasc Surg"},{"issue":"7","key":"ref140","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jvir.2011.02.017","article-title":"Additional supervised exercise therapy after a percutaneous vascular intervention for peripheral arterial disease: a randomized clinical trial","volume":"22","author":"Kruidenier LM","year":"2011","journal-title":"J Vasc Interv Radiol"},{"issue":"1","key":"ref141","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Inter-society consensus for the management of peripheral arterial disease (TASC II)","volume":"45","author":"Norgren L","year":"2007","journal-title":"J Vasc Surg"},{"issue":"6555","key":"ref142","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/bmj.293.6555.1137","article-title":"Fate in intermittent claudication: outcome and risk factors","volume":"293","author":"Jelnes R","year":"1986","journal-title":"Br Med J"},{"issue":"6","key":"ref143","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1067\/mva.2001.119749","article-title":"Natural history of claudication: long-term serial follow-up study of 1244 claudicants","volume":"34","author":"Aquino R","year":"2001","journal-title":"J Vasc Surg"},{"issue":"8","key":"ref144","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/jamasurg.2016.0415","article-title":"Efficacy of a guideline- recommended risk-reduction program to improve cardiovascular and limb outcomes in patients with peripheral arterial disease","volume":"151","author":"Hussain MA","year":"2016","journal-title":"JAMA Surg"},{"issue":"9","key":"ref145","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMcp1507631","article-title":"Clinical practice: peripheral artery disease","volume":"374","author":"Kullo IJ","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"ref146","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jvs.2017.02.040","article-title":"Medical management of claudication","volume":"66","author":"Ratchford EV","year":"2017","journal-title":"J Vasc Surg"},{"issue":"6","key":"ref147","article-title":"Cilostazol for intermittent claudication","volume":"6","author":"Brown T","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"ref148","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1001\/jama.2015.14851","article-title":"Endovascular revascularization and. supervised exercise for peripheral artery disease and intermittent claudication. a randomized clinical trial","volume":"314","author":"Spronk S","year":"2015","journal-title":"JAMA"},{"issue":"9","key":"ref149","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.jacc.2009.09.055","article-title":"The general prognosis of patients with peripheral arterial disease differs according to the disease localization","volume":"55","author":"Aboyans V","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"ref150","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.jvs.2010.04.080","article-title":"A systematic review of endovascular treatment of extensive aortoiliac occlusive disease","volume":"52","author":"Jongkind V","year":"2010","journal-title":"J Vasc Surg"},{"issue":"3","key":"ref151","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jvs.2010.03.071","article-title":"Four-year randomized prospective comparison of percutaneous ePTFE\/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease","volume":"52","author":"McQuade K","year":"2010","journal-title":"J Vasc Surg"},{"issue":"1","key":"ref152","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jvs.2016.08.095","article-title":"A network meta-analysis of randomized controlled trials comparing treatment modalities for de novo superficial femoral artery occlusive lesions","volume":"65","author":"Antonopoulos CN","year":"2017","journal-title":"J Vasc Surg"},{"issue":"9","key":"ref153","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1007\/s00270-021-02891-5","article-title":"CIRSE standards of practice on below-the-knee revascularisation","volume":"44","author":"Spiliopoulos S","year":"2021","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"5","key":"ref154","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.jvs.2011.06.106","article-title":"A meta-analysis of the outcome of endovascular and noninvasive therapies in the treatment of intermittent claudication","volume":"54","author":"Ahimastos AA","year":"2011","journal-title":"J Vasc Surg"},{"issue":"4","key":"ref155","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1067\/mva.2003.148","article-title":"Infrainguinal revascularization because of claudication: total long-term outcome of endovascular and surgical treatment","volume":"37","author":"J\u00e4ms\u00e9n TS","year":"2003","journal-title":"J Vasc Surg"},{"issue":"10","key":"ref156","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jacc.2014.12.043","article-title":"Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study","volume":"65","author":"Murphy TP","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"ref157","article-title":"Endovascular revascularisation versus conservative management for intermittent claudication","volume":"3","author":"Fakhry F","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"ref158","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jcin.2017.01.027","article-title":"Comparative efficacy of endovascular revascularization versus supervised exercise training in patients with intermittent claudication: meta-analysis of randomized controlled trials","volume":"10","author":"Pandey A","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"issue":"3","key":"ref159","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ejvs.2021.09.042","article-title":"Randomised clinical trial of supervised exercise therapy vs. endovascular revascularisation for intermittent claudication caused by iliac artery obstruction: the SUPER study","volume":"63","author":"Koelemay MJW","year":"2022","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"4","key":"ref160","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1067\/mva.2003.148","article-title":"Infrainguinal revascularization because of claudication: total long-term outcome of endovascular and surgical treatment","volume":"37","author":"J\u00e4ms\u00e9n TS","year":"2003","journal-title":"J Vasc Surg"},{"issue":"18","key":"ref161","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/j.jacc.2016.04.071","article-title":"Critical limb ischemia: an expert statement","volume":"68","author":"Shishehbor MH","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"21","key":"ref162","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1016\/j.jacc.2018.03.483","article-title":"Antithrombotic therapy for peripheral artery disease: recent advances","volume":"71","author":"Hussain MA","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"ref163","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.jvs.2015.07.065","article-title":"The natural history of untreated severe or critical limb ischemia","volume":"62","author":"Abu Dabrh AM","year":"2015","journal-title":"J Vasc Surg"},{"key":"ref164","article-title":"Effectiveness of revascularisation of the ulcerated foot in patients with diabetes and peripheral artery disease: a systematic review","volume":"36","author":"Forsythe RO","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"issue":"1","key":"ref165","first-page":"1","article-title":"Summary of the proceedings of the International Summit 2015: general and subspecialty radiology","volume":"7","year":"2015","journal-title":"Insights Imaging"},{"issue":"16","key":"ref166","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.3390\/jcm10163454","article-title":"The Global Limb Anatomic Staging System (GLASS) for CLTI: improving inter-observer agreement","volume":"10","author":"Wijnand JGJ","year":"2021","journal-title":"J Clin Med"},{"issue":"6","key":"ref167","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/j.jvs.2019.02.016","article-title":"Global vascular guidelines on the management of chronic limb-threatening ischemia","volume":"69","author":"Conte MS","year":"2019","journal-title":"J Vasc Surg"},{"issue":"1","key":"ref168","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejvs.2022.03.044","article-title":"Predictability of the Global Limb Anatomic Staging System (GLASS) for technical and limb related outcomes: a systematic review and meta-analysis","volume":"64","author":"Shirasu T","year":"2022","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"1","key":"ref169","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ejvs.2019.05.006","article-title":"Global vascular guidelines on the management of chronic ischemia, limb-threatening","volume":"58","author":"Conte MS","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"25","key":"ref170","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa2207899","article-title":"Surgery or endovascular therapy for chronic limb-threatening ischemia","volume":"387","author":"Farber A","year":"2022","journal-title":"N Engl J Med"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.avsg.2021.09.054","article-title":"Validation of the GLASS staging systems in patients with chronic limb-threatening ischemia undergoing de novo infrainguinal revascularization","volume":"81","author":"Morisaki K","year":"2022","journal-title":"Ann Vasc Surg"},{"key":"ref172","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.avsg.2019.07.017","article-title":"Association between critical limb ischemia, the Society for Vascular Surgery Wound, Ischemia and Foot Infection (WIfI) classification system and arterial stiffness","volume":"63","author":"Mendes-Pinto D","year":"2020","journal-title":"Ann Vasc Surg"},{"issue":"2","key":"ref173","doi-asserted-by":"crossref","first-page":"112","DOI":"10.23736\/S0392-9590.21.04582-X","article-title":"Neutrophil-lymphocyte ratio as a link between complex pedal ulcers and poor clinical results after infrainguinal surgical revascularization","volume":"40","author":"Gonz\u00e1lez-Hernandez J","year":"2021","journal-title":"Int Angiol"},{"issue":"5","key":"ref174","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.jvs.2018.01.060","article-title":"The Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification system predicts wound healing better than direct angiosome perfusion in diabetic foot wounds","volume":"68","author":"Weaver ML","year":"2018","journal-title":"J Vasc Surg"},{"issue":"1","key":"ref175","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ejvs.2019.05.006","article-title":"Global vascular guidelines on the management of chronic limb-threatening ischemia","volume":"58","author":"Conte MS","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"6","key":"ref176","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.jvs.2007.08.033","article-title":"Technical factors affecting autogenous vein graft failure: observations from a large multicenter trial","volume":"46","author":"Schanzer A","year":"2007","journal-title":"J Vasc Surg"},{"issue":"2","key":"ref177","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jvs.2018.01.066","article-title":"A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia","volume":"68","author":"Almasri J","year":"2018","journal-title":"J Vasc Surg"},{"issue":"4","key":"ref178","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.jvs.2020.06.049","article-title":"Implementing global chronic limb-threatening ischemia guidelines in clinical practice: Utility of the Society for Vascular Surgery Threatened Limb Classification System (WIfI)","volume":"72","author":"Conte MS","year":"2020","journal-title":"J Vasc Surg"},{"key":"ref179","article-title":"Guidelines on the classification of diabetic foot ulcers (IWGDF 2019)","volume":"36","author":"Monteiro-Soares M","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"key":"ref180","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.avsg.2020.07.033","article-title":"Predictive model for postoperative ambulatory function after lower extremity bypass in chronic limb-threatening ischemia","volume":"71","author":"Miyake K","year":"2021","journal-title":"Ann Vasc Surg"},{"issue":"7","key":"ref181","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003219","article-title":"Design and rationale of the best endo- vascular versus Best Surgical Therapy for Patients With Critical Limb Ischemia (BEST-CLI) trial","volume":"5","author":"Menard MT","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"ref182","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/00000658-198706000-00016","article-title":"Preoperative saphenous and cephalic vein mapping as an adjunct to reconstructive arterial surgery","volume":"205","author":"Seeger JM","year":"1987","journal-title":"Ann Surg"},{"issue":"6","key":"ref183","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.jvs.2007.08.033","article-title":"Technical factors affecting autogenous vein graft failure: observations from a large multicenter trial","volume":"46","author":"Schanzer A","year":"2007","journal-title":"J Vasc Surg"},{"issue":"4","key":"ref184","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.jvs.2020.10.026","article-title":"Systematic review and meta-analysis of endovascular versus open repair for common femoral artery atherosclerosis treatment","volume":"73","author":"Boufi M","year":"2021","journal-title":"J Vasc Surg"},{"issue":"2","key":"ref185","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jacc.2004.11.026","article-title":"Prevalence and clinical impact of stent fractures after femoropopliteal stenting","volume":"45","author":"Scheinert D","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"ref186","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1161\/CIRCINTERVENTIONS.109.903468","article-title":"Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial","volume":"3","author":"Laird JR","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"key":"ref187","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.avsg.2019.11.002","article-title":"Long-term patency and clinical outcomes of nitinol stenting for femoropopliteal atherosclerotic disease","volume":"66","author":"Abdoli S","year":"2020","journal-title":"Ann Vasc Surg"},{"issue":"7","key":"ref188","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/ccd.27058","article-title":"SUPERB final 3-year outcomes using interwoven nitinol biomimetic supera stent","volume":"89","author":"Garcia LA","year":"2017","journal-title":"Catheter Cardiovasc Interv"},{"issue":"1","key":"ref189","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1177\/1526602819885652","article-title":"Comparative outcomes of supera interwoven nitinol vs bare nitinol stents for the treatment of femoropopliteal disease: insights from the XLPAD registry","volume":"27","author":"Armstrong EJ","year":"2020","journal-title":"J Endovasc Ther"},{"issue":"1","key":"ref190","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1177\/1526602819897068","article-title":"Commentary: one-year outcomes of endovascular therapy of the femoropopliteal segment with supera interwoven nitinol stents: mimetism, myths, or truth?","volume":"27","author":"Diaz-Sandoval LJ","year":"2020","journal-title":"J Endovasc Ther"},{"issue":"4","key":"ref191","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.jvs.2016.04.053","article-title":"Analysis of endovascular therapy for femoropopliteal disease with the Supera stent","volume":"64","author":"Montero-Baker M","year":"2016","journal-title":"J Vasc Surg"},{"issue":"6","key":"ref192","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jcin.2021.01.026","article-title":"2-Year outcomes of the Eluvia drug-eluting stent for the treatment of complex femoropopliteal lesions","volume":"14","author":"Stavroulakis K","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"issue":"1","key":"ref193","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.117.005891","article-title":"Treatment effect of drug-coated balloons is durable to 3 years in the femoropopliteal arteries: long-term results of the IN.PACT SFA randomized trial","volume":"11","author":"Schneider PA","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"issue":"2","key":"ref194","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1406235","article-title":"Trial of a paclitaxel-coated balloon for femoropopliteal artery disease","volume":"373","author":"Rosenfield K","year":"2015","journal-title":"N Engl J Med"},{"issue":"3","key":"ref195","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.jvs.2019.01.080","article-title":"Systematic review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease","volume":"70","author":"Caradu C","year":"2019","journal-title":"J Vasc Surg"},{"issue":"1","key":"ref196","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jvs.2016.02.043","article-title":"Results from the Tack Optimized Balloon Angioplasty (TOBA) study demonstrate the benefits of minimal metal implants for dissection repair after angioplasty","volume":"64","author":"Bosiers M","year":"2016","journal-title":"J Vasc Surg"},{"issue":"24","key":"ref197","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1016\/j.jcin.2019.08.025","article-title":"Safety of paclitaxel-coated balloon angioplasty for femoropopliteal peripheral artery disease","volume":"12","author":"Ouriel K","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"issue":"38","key":"ref198","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.1093\/eurheartj\/ehz698","article-title":"Mortality after use of paclitaxel-based devices in peripheral arteries: a real-world safety analysis","volume":"41","author":"Freisinger E","year":"2020","journal-title":"Eur Heart J"},{"issue":"21","key":"ref199","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2015.09.063","article-title":"Durability of treatment effect using a drug- coated balloon for femoropopliteal lesions: 24-month results of INPACT SFA","volume":"66","author":"Laird JR","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"ref200","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/1526602819895996","article-title":"Comparative effectiveness of endovascular treatment modalities for de novo femoropopliteal lesions: a network meta-analysis of randomized controlled trials","volume":"27","author":"Zhou Y","year":"2020","journal-title":"J Endovasc Ther"},{"issue":"4","key":"ref201","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.jvs.2011.03.272","article-title":"Results of the Prot\u00e9g\u00e9 EverFlex 200-mm-long nitinol stent (ev3) in TASC C and D femoropopliteal lesions","volume":"54","author":"Bosiers M","year":"2011","journal-title":"J Vasc Surg"},{"issue":"5","key":"ref202","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCINTERVENTIONS.111.962324","article-title":"Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results","volume":"4","author":"Dake MD","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"issue":"21","key":"ref203","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1161\/CIRCULATIONAHA.122.059606","article-title":"Efficacy of a drug-eluting stent versus bare metal stents for symptomatic femoropopliteal peripheral artery disease: primary results of the EMINENT randomized trial","volume":"146","author":"Gou\u00ebffic Y","year":"2022","journal-title":"Circulation"},{"issue":"15","key":"ref204","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.115.016900","article-title":"Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the Zilver PTX randomized trial","volume":"133","author":"Dake MD","year":"2016","journal-title":"Circulation"},{"issue":"9","key":"ref205","article-title":"Atherectomy for peripheral arterial disease","volume":"9","author":"Wardle BG","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"ref206","doi-asserted-by":"crossref","first-page":"121","DOI":"10.23736\/S0392-9590.19.04049-5","article-title":"The use of drug-eluting stents in infrapopliteal arteries: an updated systematic review and meta-analysis of randomized trials","volume":"38","author":"Varcoe RL","year":"2019","journal-title":"Int Angiol"},{"issue":"7","key":"ref207","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/ccd.22658","article-title":"Angiographic patency and clinical outcome after balloon-angioplasty for extensive infrapopliteal arterial disease","volume":"76","author":"Schmidt A","year":"2010","journal-title":"Catheter Cardiovasc Interv"},{"issue":"8","key":"ref208","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.avsg.2012.02.006","article-title":"The ongoing battle between infrapopliteal angioplasty and bypass surgery for critical limb ischemia","volume":"26","author":"Schamp KBC","year":"2012","journal-title":"Ann Vasc Surg"},{"issue":"4","key":"ref209","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/152660280200900403","article-title":"Balloon angioplasty in chronic critical limb ischemia: factors affect- ing clinical and angiographic outcome","volume":"9","author":"Balmer H","year":"2002","journal-title":"J Endovasc Ther"},{"issue":"15","key":"ref210","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/j.jacc.2014.06.1198","article-title":"Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia. 12-month results from the IN. PACT DEEP randomized trial","volume":"64","author":"Zeller T","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"ref211","first-page":"1614","article-title":"Paclitaxel-coated balloon in infrapopliteal arteries: 12-month results from the BIOLUX P-II randomized trial (BIOTRONIK\u2019S-first in man study of the passeo-18 LUX drug releasing PTA balloon catheter vs. the uncoated passeo-18 PTA balloon catheter in subjects requiring revascularization of infrapopliteal arteries)","volume":"8","author":"Zeller T","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"issue":"1 Pt B","key":"ref212","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.carrev.2017.06.006","article-title":"Drug-coated balloon angioplasty for the management of recurring infrapopliteal disease in diabetic patients with critical limb ischemia","volume":"19","author":"Palena LM","year":"2018","journal-title":"Cardiovascular Revascularization Medicine."},{"issue":"3","key":"ref213","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1177\/1526602816645080","article-title":"Single-center experience with lutonix drug-coated balloons in infrapopliteal arteries","volume":"23","author":"Steiner S","year":"2016","journal-title":"J Endovasc Ther"},{"issue":"2","key":"ref214","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s00270-009-9765-6","article-title":"Angioplasty or primary stenting for infrapopliteal lesions: results of a prospective randomized trial","volume":"33","author":"Randon C","year":"2010","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"1","key":"ref215","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1177\/1538574413510626","article-title":"Systematic review and meta-analysis of balloon angioplasty versus primary stenting in the infrapopliteal disease","volume":"48","author":"Yang X","year":"2014","journal-title":"Vasc Endovascular Surg"},{"issue":"12","key":"ref216","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.jcin.2013.08.007","article-title":"Drug-eluting stents for revascularization of infrapopliteal arteries: updated meta-analysis of randomized trials","volume":"6","author":"Fusaro M","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"issue":"7","key":"ref217","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jacc.2012.04.035","article-title":"Sirolimus-eluting stents for treatment of infrapopliteal arteries reduce clinical event rate compared to bare-metal stents. Long-term results from a randomized trial","volume":"60","author":"Rastan A","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"ref218","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1583\/1545-1550-20.2.131","article-title":"Meta-analysis of outcomes of endovascular treatment of infrapopliteal occlusive disease with drug-eluting stents","volume":"20","author":"Antoniou GA","year":"2013","journal-title":"J Endovasc Ther"},{"issue":"9","key":"ref219","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.jvir.2009.05.031","article-title":"Infrapopliteal application of sirolimus-eluting versus bare metal stents for critical limb ischemia: analysis of long-term angiographic and clinical outcome","volume":"20","author":"Siablis D","year":"2009","journal-title":"J Vasc Interv Radiol"},{"issue":"1","key":"ref220","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12928-021-00758-7","article-title":"Comparative performance analysis of interventional devices for the treatment of ischemic disease in below-the-knee lesions: a systematic review and meta-analysis","volume":"37","author":"Matsuoka EK","year":"2022","journal-title":"Cardiovasc Interv Ther"},{"issue":"3","key":"ref221","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1177\/1526602817704643","article-title":"Midterm outcomes after infrapopliteal interventions in patients with critical limb ischemia based on the TASC II classification of below-the-knee arteries","volume":"24","author":"Singh GD","year":"2017","journal-title":"J Endovasc Ther"},{"issue":"2","key":"ref222","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jvs.2019.12.035","article-title":"Meta- analysis of direct surgical versus endovascular revascularization for aortoiliac occlusive disease","volume":"72","author":"Premaratne S","year":"2020","journal-title":"J Vasc Surg"},{"issue":"1S","key":"ref223","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1016\/j.ejvs.2019.04.013","article-title":"A systematic review and meta- analysis of revascularization outcomes of infrainguinal chronic limb- threatening ischemia","volume":"58","author":"Almasri J","year":"2019","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"9501","key":"ref224","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/S0140-6736(05)67704-5","article-title":"Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial","volume":"366","author":"Adam DJ","year":"2005","journal-title":"Lancet"},{"issue":"11","key":"ref225","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/jamasurg.2016.2018","article-title":"The current state of critical limb ischemia: a systematic review","volume":"151","author":"Farber A","year":"2016","journal-title":"JAMA Surg"},{"key":"ref226","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.avsg.2019.07.004","article-title":"Comparison of bypass and endovascular intervention for popliteal occlusion with the involvement of trifurcation for critical limb ischemia","volume":"63","author":"Biagioni RB","year":"2020","journal-title":"Ann Vasc Surg"},{"issue":"2","key":"ref227","article-title":"Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery","volume":"2015","author":"Bedenis R","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"ref228","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/bjs.1800731021","article-title":"Haemodynamics of the interposition vein cuff","volume":"73","author":"Beard JD","year":"1986","journal-title":"Br J Surg"},{"issue":"3","key":"ref229","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1053\/ejvs.2000.1273","article-title":"Optimising miller cuff dimensions: the influence of geometry on anastomotic flow patterns","volume":"21","author":"Fisher RK","year":"2001","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"9","key":"ref230","article-title":"Interposition vein cuff for infragenicular prosthetic bypass graft","volume":"2012","author":"Khalil AA","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"1 Pt 1","key":"ref231","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0741-5214(00)70069-3","article-title":"Vein interposition cuffs decrease the intimal hyperplastic response of polyte- trafluoroethylene bypass grafts","volume":"31","author":"Kissin M","year":"2000","journal-title":"J Vasc Surg"},{"issue":"7","key":"ref232","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1308\/rcsann.2021.0010","article-title":"Adaptation of the vein cuff in distal arterial anastomosis (Brighton Sock)","volume":"103","author":"Nash TM","year":"2021","journal-title":"Ann R Coll Surg Engl"},{"issue":"3","key":"ref233","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s10016-004-0130-6","article-title":"Infragenicular bypass graft for limb salvage using polytetra- fluoroethylene and distal vein cuff as the first alternative in patients without ipsilateral greater saphenous vein","volume":"19","author":"Aracil-Sanus E","year":"2005","journal-title":"Ann Vasc Surg"},{"issue":"6","key":"ref234","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ejvs.2004.03.002","article-title":"Interposition vein cuff and intimal hyperplasia: an experimental study","volume":"27","author":"Ducasse E","year":"2004","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"2","key":"ref235","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10016-004-0012-y","article-title":"Multicenter rand- omized prospective trial comparing a pre-cuffed polytetra- fluoroethylene graft to a vein cuffed polytetrafluoroethylene graft for infragenicular arterial bypass","volume":"18","author":"Panneton JM","year":"2004","journal-title":"Ann Vasc Surg"},{"issue":"5","key":"ref236","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S1078-5884(98)80209-8","article-title":"Polytetrafluoroethylene (PTFE) femorodistal grafts with a dis- tal vein cuff for critical ischaemia","volume":"15","author":"Wijesinghe LD","year":"1998","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"4","key":"ref237","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jvs.2012.10.098","article-title":"Distal anastomotic vein adjunct usage in infrainguinal prosthetic bypasses","volume":"57","author":"McPhee JT","year":"2013","journal-title":"J Vasc Surg"},{"key":"ref238","article-title":"Tapered reinforced graft and vein cuff in the distal anastomosis as adjunct strategies for infrapopliteal prosthetic bypass graft in chronic limb-threatening ischemia: a case report","volume":"11","author":"Dalio MB","year":"2023","journal-title":"SAGE Open Med Case Rep"},{"issue":"2","key":"ref239","article-title":"Graft type for femoro-popliteal bypass surgery","volume":"2","author":"Ambler GK","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"ref240","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ejvs.2003.12.027","article-title":"Saphenous vein versus PTFE for above-knee femoropopliteal bypass: a review of the literature","volume":"27","author":"Klinkert P","year":"2004","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"5","key":"ref241","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.jvs.2008.06.006","article-title":"Stenting vs above knee polytetrafluoroethylene bypass for TransAtlantic Inter-Society Consensus-II C and D superficial femoral artery disease","volume":"48","author":"Dosluoglu HH","year":"2008","journal-title":"J Vasc Surg"},{"issue":"14","key":"ref242","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta14140","article-title":"Multicentre randomised controlled trial of the clinical and cost-effectiveness of a bypass-surgery-first versus a balloon-angioplasty-first revascularisation strategy for severe limb ischaemia due to infrainguinal disease. The Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial","volume":"14","author":"Bradbury AW","year":"2010","journal-title":"Health Technol Assess"},{"issue":"4","key":"ref243","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/0003319719896477","article-title":"A targeted literature review of the disease burden in patients with symptomatic peripheral artery disease","volume":"71","author":"Bauersachs R","year":"2020","journal-title":"Angiology"}],"container-title":["Jornal Vascular Brasileiro"],"original-title":["Diretrizes sobre doen\u00e7a arterial perif\u00e9rica da Sociedade Brasileira de Angiologia e Cirurgia Vascular"],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S1677-54492024000101104&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T11:39:38Z","timestamp":1730115578000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S1677-54492024000101104&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":243,"alternative-id":["S1677-54492024000101104"],"URL":"https:\/\/doi.org\/10.1590\/1677-5449.202300592","relation":{"has-translation":[{"id-type":"doi","id":"10.1590\/1677-5449.202300591","asserted-by":"subject"}]},"ISSN":["1677-7301","1677-5449"],"issn-type":[{"value":"1677-7301","type":"electronic"},{"value":"1677-5449","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"e20230059"}}